91
Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.
Condition(s):HealthyLast Updated:June 22, 2007Completed
Valsartan: 524 Clinical Trials, Page 10 of 53
Hide Studies Not Open or Pending
92
Regression of Fatty Heart by Valsartan Therapy
Condition(s):Metabolic Syndrome; LipotoxicityLast Updated:January 17, 2019Withdrawn
93
Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects.
Condition(s):HealthyLast Updated:June 22, 2007Completed
94
Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD
Condition(s):Pediatric Hypertension With or Without CKDLast Updated:September 27, 2017Completed
95
Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy
Condition(s):Hypertrophic CardiomyopathyLast Updated:November 28, 2022Completed
96
To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers
Condition(s):HealthyLast Updated:June 22, 2007Completed
97
Influence of Sacubitril/Valsartan on Autonomic Cardiac Nervous System in Heart Failure Patients: an Exploratory Study
Condition(s):Heart Failure PatientsLast Updated:June 21, 2022Completed
98
Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study)
Condition(s):Hypertension; ObesityLast Updated:June 3, 2010Unknown status
99
Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide
Condition(s):Healthy Normotensive ParticipantsLast Updated:January 15, 2013Completed
100
Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study
Condition(s):Stage D Heart FailureLast Updated:June 7, 2021Unknown status